Vigred is a new drug developed by Acme Pharmaceuticals to treat high blood pressure. In clinical trials, Vigred was shown to significantly reduce systolic and diastolic blood pressure within 4 weeks without major side effects. Further research is needed, but initial results indicate Vigred may be a safe and effective new treatment option for hypertension.